Objectives: T-SPOT.TB is a promising diagnosis tool to identify both pulmonary tuberculosis and extrapulmonary tuberculosis, as well as latent tuberculosis; however, the factors that affect the results of T-SPOT.TB remains unclear. In this study, we aim to figure out the risk factor of T-SPOT.TB for active TB.
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DI anD LI screening. A total of 44 subjects with different kinds of TB were added in this study between January 1st, 2016 and November 7th, 2016, as subject with extra-pulmonary TB were relatively seldom. Finally, 349 subjects were included in our study including 98 subjects with TB and 251 subjects with non-TB disease. 24 of the 251 subjects with non-TB disease had a cured TB history ( Figure 1 ). Clinical information of patients was collected from hospital information system (Table 1) . These information included: sex, age, onset time, smoke history, alcohol history, treatment (non-anti TB) history, allergic history, co-morbidity (include kidney stone, COPD, anemia, central nervous system (CNS) infection, myocardial infarction, diabetes, pulmonary infection, pleural effussion, liver dysfunction, hypertension, malignancy, urinary infection, pyemia), TB (include pulmonary tuberculosis, tuberculous meningitis, tuberculous pleurisy, intestinal tuberculosis, tuberculosis synovitis, spinal tuberculosis, pelvic tuberculosis, urinary tuberculosis and lymph node tuberculosis) and cured TB history with other disease.
Confirmed TB had to satisfy one of following conditions: (1) identification of bacillus in specimen or tissue by acid fast staining, or by culture, or by PCR, or by the pathological report; and (2) clinical, radiographic, and other supporting test programs characteristics and medical history suggested TB. Meanwhile, TB were diagnosed by physicians and patients improved with anti-TB treatment. Confirmed non-TB had to satisfy the following: (1) clinical, radiographic, and other supporting test programs characteristics and medical history suggest non-TB; and (2) diagnosed non-TB by physicians and improved without anti-TB treatment. All diagnoses were made by two physicians. If the two physicians were divided about the diagnosis, then a third physician was referred.
Exclusion criteria included: (1) any indeterminate diagnosis judged by physicians; and (2) multiple lesions in different tissue or system.
| T-SPOT.TB assay
We carried out the T-SPOT.TB test (Oxford Immunotec Ltd, Oxford, UK) according to the manufacturer's instructions. Peripheral blood (5 mL) of subjects included in our study was collected into sodium heparin tubes, than diluted by an equal volume of RPMI 1640 medium (Shanghai 
| Statistical analysis

| RESULT
| Diagnostic efficiency of T-SPOT.TB
In this study, the specificity and sensitivity of the T-SPOT.TB was 
| Risk factor of false-negative
To investigate the risk factor of false-negative, logistic regression analysis was performed involving different variable including sex, age, onset time, smoke, alcohol, treatment, allergic, co-morbidity and TB type. Multiple logistic regression was performed if P value lower than .20 in binary logistic regression. The result suggested that sex, age between 30 and 60 years, age >60 years, onset time, smoke, alcohol, treatment, allergic, co-morbidity and TB type excluding tuberculous meningitis play no significant role in false-negative. Age <30 and tuberculous meningitis was significant in binary logistic regression.
However, only tuberculous meningitis whose OR value, 95% CI and P value was 17.4, (3.068,98.671), <0.001, respectively, was significant in multiple logistic regression. The rest of variable such as sex, age between 30 to 60, age ≥60, onset time, smoke, alcohol, treatment, allergic history, co-morbidity, pulmonary tuberculosis, tuberculous pleurisy, intestinal tuberculosis, tuberculosis synovitis, spinal tuberculosis, pelvic tuberculosis, urinary tuberculosis and lymph node tuberculosis were not the risk factor (P>.05) of false-negative (Table 2 ). .698
| Risk factor of false-positive
Co-morbidity .918
Co-morbidity Kidney stone . 
| Dummy variables analysis
To investigate the relationship between dummy variables, we analyzed three dummy variables in age group or onset time group. Age <30 (n=21 in false-negative; n=101 in false positive) group was defined (Table 4) .
| DISCUSSION
Our study demonstrated the performance of T-SPOT.TB. For diagnostic efficiency, the T-SPOT.TB performed well-the overall specificity and sensitivity of the T-SPOT.TB was 92.83% (233/251) and 83.67% (82/98), respectively. However, the sensitivity of T-SPOT.TB in various TB was more or less affected by its limited sample size.
For risk factor of false-negative, the initial binary logistic regression analysis indicated that age and tuberculous meningitis were risk factor for false-negative. After multiple logistic regression analysis, age was proved to be not the risk factor of false-negative. We found that age<30 group was affected by tuberculous meningitis group, that could be the reason why age<30 group in binary logistic regression analysis was risk factor but not in multiple logistic regression analysis.
For risk factor of false-positive, sex, age between 30 and 60, age ≥60, smoke, alcohol, diabetes and cured TB was significant in binary logistic analysis, but only cured TB was confirmed as the risk factor of false-positive. Similarly, these variables were significant in binary logistic regression due to the effect of cured TB. Although our results indicated that age was not the risk factor for both sensitivity and specificity, it was contradictory among reports. The specificity of T.SPOT.TB were affected by age in some reports 9,10 while other reports suggested that age did not affect the result of T.SPOT.TB.
11,12
Onset time was not risk factor according to our results, while Pan et al. 9 reported that period of illness longer than 6 months was risk factors for false-negative results.
Our study indicated that tuberculous meningitis was risk factor of false-negative, and the sensitivity of T-SPOT.TB in patients with tuberculous meningitis was only 25.00% (2/8). That could partly due to the strict exclusion criterion, which excluded a few indeterminate diagnosis of tuberculous meningitis making the sensitivity lower relatively.
However, the performance of T-SPOT.TB in tuberculous meningitis is controversial. Qin et al. 13 reported that sensitivity and specificity in patients with tuberculous meningitis was 83.00% and 82.00%, respectively. Lu et al. 14 reported that sensitivity and specificity in patients with tuberculous meningitis was 70% and 87% respectively. In contrast, a prospect study suggested that tuberculous meningitis might be risk factor for false-negative (OR=2.6; 95% CI 1.0-6.6). 6 Due to the limited sample size of patients, some kind of TB were not credible relatively such as tuberculosis synovitis (n=3). However, the T-SPOT.
TB performance in tuberculosis synovitis was rarely reported. Cheng et al. 15 reported that the sensitivity and specificity of T-SPOT.TB in patients with tuberculosis synovitis (n=6) was 67% and 69%, respectively. For other kinds of TB, a meta-analysis noted that the sensitivity and specificity of T-SPOT.TB and/or QFT in patients with tuberculous
Pericarditis were 0.77 (95% CI, 0.71-0.83) and 0.71 (95% CI, 0.65-0.76), respectively 16 while Bian et al. 17 reported that sensitivity and specificity in tuberculous Pericarditis was 83% and 95%, respectively.
Jia et al. 18 noted that the overall sensitivity and specificity of T-SPOT. There were some limitations in our study. Firstly, due to the limited conditions, LTBI patients was not discussed in our study. Secondly, subjects in some kind of TB type were seldom, that could more or less affect our results. Thirdly, the variable of malignancy was not concrete while the characteristic of malignancies vary from each other.
Fourthly, anti-TB treatment was not enrolled in our study as must of subject were initial treatment. Fifthly, BCG vaccination patient were not discussed in our study. Sixthly, because of the low distribution of HIV-positive subjects in China, these individuals were not seriously distinguished in our study.
